Inhibition of drug transporter breast cancer resistance protein has no effect on the pharmacokinetics of major active metabolites of ozanimod

被引：0
|
作者：
Zhang, P. [1 ]
Ghosh, A. [1 ]
Thomas, M. [1 ]
Wang, X. [1 ]
Palmisano, M. [1 ]
Tran, J. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0343
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [21] Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects
    Csonka, Denes
    Bruderer, Shirin
    Schultz, Armin
    Soergel, Marianne
    Stepanova, Radka
    Sabattini, Giancarlo
    Perez-Ruixo, Juan Jose
    CLINICAL DRUG INVESTIGATION, 2019, 39 (12) : 1223 - 1232
  • [22] Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects
    Dénes Csonka
    Shirin Bruderer
    Armin Schultz
    Marianne Soergel
    Radka Stepanova
    Giancarlo Sabattini
    Juan Jose Perez-Ruixo
    Clinical Drug Investigation, 2019, 39 : 1223 - 1232
  • [23] Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability
    Garg, Prabha
    Dhakne, Rahul
    Belekar, Vilas
    MOLECULAR DIVERSITY, 2015, 19 (01) : 163 - 172
  • [24] Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability
    Prabha Garg
    Rahul Dhakne
    Vilas Belekar
    Molecular Diversity, 2015, 19 : 163 - 172
  • [25] Inhibition of Breast Cancer Resistance Protein (BCRP) by Ko143 Can Affect Pharmacokinetics of Enrofloxacin in Exopalaemon carinicauda
    Qianqian Zhai
    Yang Xu
    Cuiping Li
    Yanyan Feng
    Yanting Cui
    Li Ma
    Jian Li
    Journal of Ocean University of China, 2020, 19 : 1116 - 1124
  • [26] Inhibition of Breast Cancer Resistance Protein (BCRP) by Ko143 Can Affect Pharmacokinetics of Enrofloxacin inExopalaemon carinicauda
    Zhai, Qianqian
    Xu, Yang
    Li, Cuiping
    Feng, Yanyan
    Cui, Yanting
    Ma, Li
    Li, Jian
    JOURNAL OF OCEAN UNIVERSITY OF CHINA, 2020, 19 (05) : 1116 - 1124
  • [27] Inhibition of Breast Cancer Resistance Protein(BCRP) by Ko143 Can Affect Pharmacokinetics of Enrofloxacin in Exopalaemon carinicauda
    ZHAI Qianqian
    XU Yang
    LI Cuiping
    FENG Yanyan
    CUI Yanting
    MA Li
    LI Jian
    JournalofOceanUniversityofChina, 2020, 19 (05) : 1116 - 1124
  • [28] The antiepileptic drug lamotrigine is a substrate of breast cancer resistance protein
    Roemermann, Kerstin
    Fedrowitz, Maren
    Loscher, Wolfgang
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S79 - S79
  • [29] Gefitinib reverses breast cancer resistance protein-mediated drug resistance
    Yanase, K
    Tsukahara, S
    Asada, S
    Ishikawa, E
    Imai, Y
    Sugimoto, Y
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (09) : 1119 - 1125
  • [30] Reversal of breast cancer resistance protein-mediated drug resistance by tryprostatin A
    Woehlecke, H
    Osada, H
    Herrmann, A
    Lage, H
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (05) : 721 - 728
12345